Evidence map›Paper›PMID 37488558›Full record

ArticleJournal of biological engineering2023

An injectable, self-healing, electroconductive hydrogel loaded with neural stem cells and donepezil for enhancing local therapy effect of spinal cord injury.

Tiemei Liu, Qiang Zhang, Hongru Li, Xiaoqian Cui, Zhiping Qi, Xiaoyu Yang

Open access · goldAbstract read
In one paragraph

Article in Journal of biological engineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Autonomous Implants.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tiemei LiuDepartment of Blood Transfusion, China-Japan Union Hospital of Jilin University, 130033, Changchun, China.
Qiang ZhangDepartment of Orthopaedic Surgery, The Second Hospital of Jilin University, 130041, Changchun, China.
Hongru LiDepartment of Orthopaedic Surgery, The Second Hospital of Jilin University, 130041, Changchun, China.
Xiaoqian CuiDepartment of Emergency and Critical Care, The Second Hospital of Jilin University, 130041, Changchun, PR China.
Zhiping QiDepartment of Orthopaedic Surgery, The Second Hospital of Jilin University, 130041, Changchun, China. qizp@jlu.edu.cn.
Xiaoyu YangDepartment of Blood Transfusion, China-Japan Union Hospital of Jilin University, 130033, Changchun, China. yangxiaoy@jlu.edu.cn.
Second Affiliated Hospital of Jilin University · CNUnion Hospital · CN

Funding

Bethune Project of Jilin University 2022B43Jilin Province science and technology development Foundation of Jilin Provincial Science and Technology Department 20230508069RCNational Natural Science Foundation of China No.82171388Natural Science Foundation of Jilin Provincial Science and Technology Department 20200201454JC
6 · The paper itself

Abstract

backgroundSpinal cord injury (SCI) is a serious injury with high mortality and disability rates, and there is no effective treatment at present. It has been reported that some treatments, such as drug intervention and stem cell transplantation have positive effects in promoting neurological recovery. Although those treatments are effective for nerve regeneration, many drawbacks, such as low stem cell survival rates and side effects caused by systemic medication, have limited their development. In recent years, injectable hydrogel materials have been widely used in tissue engineering due to their good biocompatibility, biodegradability, controllable properties, and low invasiveness. The treatment strategy of injectable hydrogels combined with stem cells or drugs has made some progress in SCI repair, showing the potential to overcome the drawbacks of traditional drugs and stem cell therapy.

methodsIn this study, a novel injectable electroactive hydrogel (NGP) based on sodium hyaluronate oxide (SAO) and polyaniline-grafted gelatine (NH

resultsThe NGP hydrogel has a suitable pore size, good biocompatibility, excellent conductivity, and injectable and self-repairing properties, and its degradation rate matches the repair cycle of spinal cord injury. In addition, DPL could be released continuously and slowly from the NGP hydrogel; thus, the NGP hydrogel could serve as an excellent carrier for drugs and cells. The results of in vitro cell experiments showed that the NGP hydrogel had good cytocompatibility and could significantly promote the neuronal differentiation and axon growth of NSCs, and loading the hydrogel with DPL could significantly enhance this effect. More importantly, the NGP hydrogel loaded with DPL showed a significant inhibitory effect on astrocytic differentiation of NSCs in vitro. Animal experiments showed that the combination of NGP hydrogel, DPL, and NSCs had the best therapeutic effect on the recovery of motor function and nerve conduction function in rats. NGP hydrogel loaded with NSCs and DPL not only significantly increased the myelin sheath area, number of new neurons and axon area but also minimized the area of the cystic cavity and glial scar and promoted neural circuit reconstruction.

conclusionsThe DPL- and NSC-laden electroactive hydrogel developed in this study is an ideal biomaterial for the treatment of traumatic spinal cord injury.

Indexed as

ConductivityDonepezilHydrogelNeural stem cellsSpinal cord injury

Identifiers

PMID37488558
PMCPMC10367392
OpenAlexW4385219787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.